Aurobindo Pharma secures FDA approval for Fingolimod Capsules

Aurobindo Pharma secures FDA approval for Fingolimod Capsules

In a significant development for the pharmaceutical industry, Aurobindo Pharma Limited has announced receiving the final nod from the United States Food and Drug Administration (USFDA) to manufacture and market Fingolimod Capsules, 0.5 mg. This approval marks a crucial milestone, as these capsules are recognized as bioequivalent and therapeutically equivalent to the reference listed drug, […]

FDA approves Genentech’s Ocrevus for multiple sclerosis treatment

Roche Group’s subsidiary Genentech has secured the US FDA approval for its multiple sclerosis drug, Ocrevus (ocrelizumab) for treating both relapsing and primary progressive variants of the chronic disease through intravenous infusion.

FDA approves Genentech’s Ocrevus for multiple sclerosis treatment

In a landmark decision, the US Food and Drug Administration (FDA) has granted approval to Genentech, a subsidiary of the Roche Group, for its multiple sclerosis (MS) drug, Ocrevus (ocrelizumab). This approval marks Ocrevus as the first and only therapy available for both relapsing and primary progressive forms of multiple sclerosis, addressing a significant unmet […]